PCX12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCX12, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) [Phase 1]